Comment on Herring et al. The Use of "Retardation" in FRAXA, FMRP, FMR1 and Other Designations. Cells 2022, 11, 1044.
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Bruford, Elspeth https://orcid.org/0000-0002-8380-5247
On Behalf Of The Hugo Gene Nomenclature Committee Hgnc
Abstract
This commentary is written in response to the recent article from Herring et al., discussing the eradication of the offensive term "retardation" from gene nomenclature. We discuss the work of the HUGO (Human Genome Organisation) Gene Nomenclature Committee (HGNC) and outline the steps already taken to remove this term from our gene names. We also highlight the latest nomenclature changes made as a result of discussions with the authors and agreement with the European Fragile X Network.
Description
Keywords
FMR1, FRAXA, HGNC, fragile X syndrome, gene nomenclature, Fragile X Mental Retardation Protein, Fragile X Syndrome, Humans
Journal Title
Cells
Conference Name
Journal ISSN
2073-4409
2073-4409
2073-4409
Volume Title
11
Publisher
MDPI AG
Publisher DOI
Sponsorship
NHGRI NIH HHS (U24 HG003345)
Wellcome Trust (208349/Z/17/Z)
Wellcome Trust (208349/Z/17/Z)